Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort study (Q33805619)

29 July 2017

title

Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort study (English)

1 reference

29 July 2017

0 references

Christopher J Hoffmann

object named as

Christopher J Hoffmann

series ordinal

1

0 references

Salome Charalambous

series ordinal

2

object named as

Salome Charalambous

1 reference

29 July 2017

4

Lynn Morris

1 reference

29 July 2017

6

Richard E Chaisson

1 reference

29 July 2017

5

Gavin J Churchyard

1 reference

29 July 2017

3

Alison D Grant

1 reference

29 July 2017

publication date

1 February 2014

1 reference

Tropical Medicine and International Health

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

236-239

1 reference

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Use of Self-Reported Adherence and Keeping Clinic Appointments as Predictors of Viremia in Routine HIV Care in the Gambia

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Viral load monitoring as a tool to reinforce adherence: a systematic review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

HIV viral load monitoring in resource-limited regions: optional or necessary?

4 July 2018

1 reference

Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects

21 January 2018

1 reference

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali

21 January 2018

1 reference

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

21 January 2018

1 reference

HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand

21 January 2018

1 reference

Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070658

Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24588012

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Measuring medication adherence: are missed doses reported more accurately then perfect adherence?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24588012

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/TMI.12237

1 reference

29 July 2017

1 reference

29 July 2017

1 reference